BUZZ-Broker Opinion: Levi's explores new growth avenues beyond its jeans business
路透社2026/10/08 14:14October 8 – Levi Strauss (LEVI.N) shares fell about 4% in early trading to $18.79. Boosted by tariff rebates and strong expected demand for high-end jeans and sweaters during the holiday season, the company raised its annual earnings outlook on Wednesday. The median price target among the 16 brokers covering the stock is $26.50, according to data compiled by LSEG. Business diversification is starting to show results. Barclays noted that Levi's expansion beyond jeans is paying off, with tops, women's wear, and emerging lifestyle categories contributing about half of the company’s growth, while it remains the leader in the U.S. jeans market. JPMorgan (rating: "Overweight", price target: $33) believes the slowdown in the direct-to-consumer business is only temporary, mainly due to hot weather in Europe and a misjudgment of U.S. jeans trends, as the business has already started to rebound in this quarter. BTIG (rating: "Buy", price target: $27) said improved demand trends and strong performance in wholesale, international markets, and new categories support a more optimistic outlook for the holiday season and 2027. Needham ("Buy", price target: $28) noted that the temporary weakness in Levi's own stores and website seems to have started to reverse, while growth from tops, women's wear, and other non-jeans categories indicates the brand’s dependence on jeans is declining.
October 8 - ** Levi Strauss LEVI.N shares fell about 4% in early trading to $18.79
** Boosted by duty drawback and expecting strong demand for its premium jeans and sweaters during the holiday season, the company raised (link) its annual profit outlook on Wednesday
** The median target price from 16 brokerages covering the stock is $26.50—data compiled by LSEG
Diversification efforts are showing results
** Barclays stated that Levi's expansion beyond jeans is delivering results, with tops, womenswear, and emerging lifestyle categories contributing about half of the company’s growth, while it continues to hold a leading position in the US jeans market
** JPMorgan (rating "Overweight", target price: $33) believes the slowdown in the direct-to-consumer business is only temporary, mainly due to hot weather in Europe and a misread of denim trends in the US. Sales in this segment have already started to rebound this quarter
** BTIG (rated "Buy", target price: $27) said that improving demand trends along with strong performance in wholesale, international markets, and new categories supports a more optimistic outlook for the holiday season and 2027
** Needham ("Buy", target price: $28) said that the temporary softness at Levi's own stores and website seems to be reversing, and the growth from tops, womenswear, and other non-denim categories shows that the brand is becoming less dependent on jeans
(To facilitate non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or may not capture the required context, Reuters does not guarantee the accuracy of automated translated texts and provides them solely for reader convenience. Reuters shall not be liable for any damage or loss caused by the use of automated translation features.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Third Life World signs deal to buy voting control of Transglobal Management Group
Third Life World signed a definitive control share purchase agreement to take voting control of Transglobal Management Group (TMGI). The deal transfers a Series A Preferred control block holding a majority of voting rights to Third Life World. TMGI plans to make Third Life World’s AI-agent virtual world platform its core operating business. TMGI will create new Series B Preferred Stock to support the purchase; closing remains subject to customary conditions. At closing, controlling shareholder Marc Angell will resign his officer roles and stay on as a consultant during the transition. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transglobal Management Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081100PRIMZONEFULLFEED9842281) on October 08, 2026, and is solely responsible for the information contained therein.
Active Measures To Increase XRP Price. Here’s the Latest
STRK breaks through 0.06 USDT, up more than 25% in 24 hours
BUZZ-CSL plans to convert all its plasma centers in the US to use Haemonetics equipment, driving the company's stock price to soar
October 8 – ** Shares of medical device manufacturer Haemonetics (HAE.N) surged nearly 16% to $117.81 ** The stock hit an intraday high of $120.61, marking its highest level since early 2021 ** The company stated that CSL Plasma, a subsidiary of Australia’s CSL Group (CSL.AX), expects to transition all its U.S. plasma collection centers to using HAE’s NexSys devices and kits by the end of 2027 ** CSL has also terminated its agreement with HAE rival Terumo (Terumo 4543.T) – according to BTIG ** This transition will help HAE win back business lost since 2021, when its largest plasma client CSL announced it would not renew its U.S. supply contract ** BTIG estimates that, based on approximately $155 million in revenue HAE generated from CSL’s U.S. business in fiscal year 2024, this account could add about $0.60 per share to adjusted earnings annually, though it notes that actual revenue and profit margins remain unclear ** The brokerage maintained its “Buy” rating and raised its price target from $110 to $130, stating that the deal alleviates market share loss concerns and boosts sales growth prospects ** Including today’s gains, the stock is up 49.46% so far this year (For the convenience of non-English speakers, Reuters provides its reports in several other languages through automated translation. Because automated translation may be inaccurate or lack needed context, Reuters does not guarantee the accuracy of the automated text, which is offered purely as a reader service. Reuters accepts no liability for any damage or loss caused by the use of automated translation services.)
Crypto prices
More
